Cargando…
Induction of Colonic Regulatory T Cells by Mesalamine by Activating the Aryl Hydrocarbon Receptor
BACKGROUND & AIMS: Mesalamine is a first-line drug for treatment of inflammatory bowel diseases (IBD). However, its mechanisms are not fully understood. CD4(+) Foxp3(+) regulatory T cells (Tregs) play a potential role in suppressing IBD. This study determined whether the anti-inflammatory activi...
Autores principales: | Oh-oka, Kyoko, Kojima, Yuko, Uchida, Koichiro, Yoda, Kimiko, Ishimaru, Kayoko, Nakajima, Shotaro, Hemmi, Jun, Kano, Hiroshi, Fujii-Kuriyama, Yoshiaki, Katoh, Ryohei, Ito, Hiroyuki, Nakao, Atsuhito |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5453907/ https://www.ncbi.nlm.nih.gov/pubmed/28593185 http://dx.doi.org/10.1016/j.jcmgh.2017.03.010 |
Ejemplares similares
-
Lactobacillus bulgaricus OLL1181 activates the aryl hydrocarbon receptor pathway and inhibits colitis
por: Takamura, Takeyuki, et al.
Publicado: (2011) -
Ethyl Caffeate Can Inhibit Aryl Hydrocarbon Receptor (AhR) Signaling and AhR-Mediated Potentiation of Mast Cell Activation
por: Nguyen, Phuc-Tan, et al.
Publicado: (2023) -
The Putatively Specific Synthetic REV-ERB Agonist SR9009 Inhibits IgE- and IL-33-Mediated Mast Cell Activation Independently of the Circadian Clock
por: Ishimaru, Kayoko, et al.
Publicado: (2019) -
The aryl hydrocarbon receptor: a multifunctional chemical sensor for host
defense and homeostatic maintenance
por: Kawajiri, Kaname, et al.
Publicado: (2016) -
Resveratrol inhibits IL-33–mediated mast cell activation by targeting the MK2/3–PI3K/Akt axis
por: Nakajima, Shotaro, et al.
Publicado: (2019)